Jonathan Buzzell, MD
Orthopaedic Surgery · Omaha, NENPI 1215084199
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $23,588 of the $32,640 with a category attached, or 72.3%. Depuy Synthes Products, Inc. accounts for 77.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $7,878 and has fallen 97.9% since, to $166 in 2025. Among orthopaedic surgery clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $429.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$25K
- Johnson & Johnson$3K
- Conetic Solutions, Inc.$2K
- Arthrex$2K
- Stryker$531
- Seqirus USA Inc$30
- plus $97 from 7 others
What the payments were for
- Consulting fees$23,58872%
- Travel & lodging$5,02115%
- Food & beverage$1,6315%
- Education$2,4007%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 19 | $25,428 |
| Johnson & Johnson(2 entities) | 34 | $3,019 |
| Conetic Solutions, Inc. | 5 | $1,915 |
| Arthrex | 4 | $1,620 |
| Stryker | 5 | $531 |
| Seqirus USA Inc | 2 | $30 |
| Smith+Nephew | 1 | $21 |
| FX Shoulder Solutions, Inc | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| AbbVie | 1 | $13 |
| Amgen | 1 | $13 |
| Novo Nordisk | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOLOX DELTA$12,566
- DELTA$12,290
- INHANCE$1,664
- ATTUNE$896
- AEQUALIS ASCEND FLEX$377
- GLOBAL$328
- AEQUALIS PERFORM REVERSED$131
How this compares
$32,640 in reported general payments places this provider in the 90th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 38 | $44 |
| Amoxicillin | 22 | $22 |
| Clindamycin Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Omaha
- Edward FehringerOmaha$2M
- Joshua UrbanOmaha$475K
- Sayfe JassimOmaha$460K
- Beau KildowOmaha$353K
- Matthew DilisioOmaha$58K
- Samuel DubrowOmaha$34K
- Michael StojanovicOmaha$22K
- Kirk HuttonOmaha$15K
- Sean McGarryOmaha$12K
- Clayton ThorOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.